These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 3928553

  • 21. Agglutination assay of bladder cells by Concanavalin A proved the high susceptibility of analbuminemic rats to bladder carcinogens.
    Honma Y, Kakizoe T, Komatsu H, Niijima T, Sugimura T, Nagase S.
    Cancer Lett; 1983 May; 19(1):7-11. PubMed ID: 6850570
    [Abstract] [Full Text] [Related]

  • 22. Malignant transformation of urinary bladder in humans and in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-exposed Fischer rats: ultrastructure of the major components of the permeability barrier.
    Merk FB, Pauli BU, Jacobs JB, Alroy J, Friedell GH, Weinstein RS.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2843-53. PubMed ID: 872113
    [No Abstract] [Full Text] [Related]

  • 23. Evaluation of the effects of cotinine and nicotine-N'-oxides on the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    LaVoie EJ, Shigematsu A, Rivenson A, Mu B, Hoffmann D.
    J Natl Cancer Inst; 1985 Dec; 75(6):1075-81. PubMed ID: 3865011
    [Abstract] [Full Text] [Related]

  • 24. Effect of regenerative hyperplasia on the urinary bladder: carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Cohen SM, Murasaki G, Fukushima S, Greenfield RE.
    Cancer Res; 1982 Jan; 42(1):65-71. PubMed ID: 7053869
    [No Abstract] [Full Text] [Related]

  • 25. Effect of dose on the induction of urothelial proliferation by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and its relationship to bladder carcinogenesis in the rat.
    Hasegawa R, Cohen SM, St John M, Cano M, Ellwein LB.
    Carcinogenesis; 1986 Apr; 7(4):633-6. PubMed ID: 3698195
    [Abstract] [Full Text] [Related]

  • 26. Mutagenicity of urine of various species fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or 2-amino-4-(5-nitro-2-furyl)thiazole.
    Hayashida S, Wang CY.
    Mutat Res; 1984 Mar; 135(3):169-73. PubMed ID: 6369128
    [Abstract] [Full Text] [Related]

  • 27. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Rice JR, Spry LA, Zenser TV, Davis BB.
    Cancer Res; 1988 Jan 15; 48(2):304-9. PubMed ID: 3121171
    [Abstract] [Full Text] [Related]

  • 28. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis.
    Murasaki G, Zenser TV, Davis BB, Cohen SM.
    Carcinogenesis; 1984 Jan 15; 5(1):53-5. PubMed ID: 6690086
    [Abstract] [Full Text] [Related]

  • 29. Uridine 5'-diphosphate galactose: glycoprotein galactosyl transferase activity in exfoliated bladder epithelial cells in rats fed N-(4-(5-nitro-2-furyl)-2-thiazolyl) formamide.
    Plotkin GM, Brigham SC, Wolf G, Jacobs JB, Arai M.
    Cancer Biochem Biophys; 1977 Jan 15; 2(2):59-63. PubMed ID: 99227
    [Abstract] [Full Text] [Related]

  • 30. The influence of N-[4-(5-nitro-2-Furyl)-2-thiazolyl]formamide and phenacetin on the immune status in male Fischer rats.
    Johansson S, Cohen SM, Yang JP, Arai M, Friedell GH.
    Invest Urol; 1978 Jan 15; 15(4):308-77. PubMed ID: 342446
    [Abstract] [Full Text] [Related]

  • 31. Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms.
    Daskal Y, Soloway MS, DeFuria MD, Crooke ST.
    Cancer Res; 1980 Feb 15; 40(2):261-7. PubMed ID: 7356509
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of aspirin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced epithelial proliferation in the urinary bladder and forestomach of the rat.
    Hasegawa R, St John M, Murasaki G, Fukushima S, Cohen SM.
    Cancer Lett; 1984 Jan 15; 21(3):269-75. PubMed ID: 6692345
    [Abstract] [Full Text] [Related]

  • 34. Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
    Soloway MS, Martino C, Hyatt C, Marrone JC.
    Natl Cancer Inst Monogr; 1978 Dec 15; (49):293-300. PubMed ID: 748783
    [Abstract] [Full Text] [Related]

  • 35. Abnormal renal response to twenty-four-hour dehydration and fasting in Nagase analbuminemic rats.
    Yaschuk DM, Sanker JM, Zhou J, Wilson N, Keeler R.
    Lab Anim Sci; 1991 Dec 15; 41(6):577-80. PubMed ID: 1667201
    [Abstract] [Full Text] [Related]

  • 36. The pathogenesis of experimental bladder cancer.
    Bryan GT.
    Cancer Res; 1977 Aug 15; 37(8 Pt 2):2813-6. PubMed ID: 326392
    [Abstract] [Full Text] [Related]

  • 37. Long term dose response study of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced urinary bladder carcinogenesis.
    Arai M, St John M, Fukushima S, Friedell GH, Cohen SM.
    Cancer Lett; 1983 Apr 15; 18(3):261-9. PubMed ID: 6850560
    [Abstract] [Full Text] [Related]

  • 38. Effect of phenobarbital on the carcinogenesis of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Wang CY, Garner CD, Hirose M.
    Cancer Lett; 1983 Jul 15; 19(3):305-10. PubMed ID: 6883313
    [Abstract] [Full Text] [Related]

  • 39. Co-carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for the urinary bladder.
    Murasaki G, Cohen SM.
    Carcinogenesis; 1983 Jul 15; 4(1):97-9. PubMed ID: 6821891
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.